How Long to Quarantine After COVID-19 Exposure

Most people who are going to develop COVID-19 after an exposure will show symptoms within about three to five days, and formal quarantine recommendations have historically centered on a five-day window after last contact with an infected person. As of 2024, the CDC no longer recommends a specific mandatory quarantine period for exposed individuals, instead advising symptom monitoring, masking, and testing. But the biology behind the old timelines still matters if you want to make smart decisions about protecting the people around you, because the virus follows a fairly predictable schedule regardless of what any agency recommends.

What the Incubation Period Tells You

The incubation period is the gap between when the virus enters your body and when you first feel sick. For the Omicron variants that have dominated since late 2021, that gap has gotten shorter compared to earlier strains. A large French study found the mean incubation period for Omicron was about 3.6 days, compared with roughly 4.4 days for Delta and 4.6 days for the original strain.¹ A Japanese study during the Omicron BA.5 wave put the mean even shorter, at about 2.6 days.² Estimates vary depending on the study population and method used. One analysis that adjusted for growth-rate differences between variants found mean incubation periods closer to four days for both Delta and Omicron.³

What this means in practice: if you were exposed to someone with COVID, you will most likely know within three to five days whether you caught it. A small fraction of people take longer, up to about ten days in rare cases with earlier variants, but Omicron’s shorter incubation window is the reason the five-day quarantine became standard in the first place. Waiting five days after your last exposure captures the vast majority of people who are going to develop symptoms.

When You Are Actually Contagious

Quarantine timelines are built around infectiousness, not just symptoms. And the virus’s contagious window does not perfectly match when you feel sick. Viral load in the upper respiratory tract tends to peak right around or just before symptom onset, then gradually declines.⁴ A prospective cohort study that tracked individuals from before they became infectious found that the median duration of infectiousness was five days, with about two-thirds of participants still shedding live virus at day five after symptom onset and roughly a quarter still doing so at day seven.⁵

A meta-analysis focused specifically on the Omicron variant found the pooled duration of live-virus shedding in the upper respiratory tract was about five days, while PCR tests stayed positive for nearly eleven days on average.⁶ That gap is important: PCR positivity does not equal contagiousness. A systematic review found no study that could culture live virus beyond nine days after symptom onset, even when PCR-detectable viral RNA remained high.⁴ So for most people, the window where they can spread the virus to others closes well before their PCR tests turn negative.

Why Presymptomatic Spread Matters for Your Quarantine Timing

One of the trickiest aspects of COVID quarantine is that a large share of transmission happens before the infected person knows they are sick. Analyses of transmission chains in Singapore and Tianjin estimated that somewhere between 40% and 80% of transmission events occurred before the source person had symptoms.⁷ A U.S.-based modeling study estimated that presymptomatic transmission consistently contributed over half of daily new infections and over half of the effective reproduction number throughout most of 2020.⁸

This is the core rationale for quarantine after exposure rather than just after symptom onset. If you wait until you feel sick to isolate, you have likely already had one or two days of peak or near-peak viral shedding around the people in your life. A quarantine period that begins at the time of exposure, rather than at symptom onset, catches that presymptomatic window. It is also why rapid testing on day five or so after exposure became a practical alternative to a longer quarantine: the test catches people who are presymptomatic but already shedding virus.

Using Rapid Tests to Shorten or End Your Quarantine

Rapid antigen tests are most useful when viral load is high, which typically means the first few days after symptoms appear. Their sensitivity drops off outside that window. One study found that for nasal swab specimens collected within the first five days of symptoms, sensitivity exceeded 89%.⁹ When used in asymptomatic close contacts, though, the overall sensitivity of a single rapid test was much lower. An evaluation in close contacts of confirmed cases found only about 48% sensitivity compared to PCR.¹⁰ A negative rapid test right after exposure, in other words, tells you very little.

The math changes if you test later and test more than once. Modeling work published in eLife found that a seven-day quarantine paired with a PCR test on day five performed almost as well as a full ten-day quarantine in terms of preventing onward transmission. Using rapid antigen tests, the quarantine could be shortened to six days with comparable results.¹¹ The practical takeaway: a single rapid test on day one after exposure is close to useless for ruling out infection. Testing on days four to six gives you a much better signal, and two negative rapid tests spaced a day or two apart are more reliable than one.

One caveat about using a negative rapid test to “clear” yourself: the negative predictive value of a rapid test compared to viral culture was about 91% in one study, meaning roughly one in ten people who tested negative on the rapid test were still shedding live virus.¹² That is pretty good but not foolproof, especially if you are about to spend time with someone who is elderly or immunocompromised.

How Vaccination and Prior Infection Affect the Timeline

Your immune history changes how quickly your body deals with the virus once it takes hold. Among people infected with the Delta variant, fully vaccinated individuals cleared the virus from their upper respiratory tract in an average of about 11 days, compared to roughly 14 days for unvaccinated people.¹³ A larger study found that people with two or three vaccine doses achieved negative conversion about a day faster on average than those with fewer doses.¹⁴ The same study found that people whose most recent vaccination was more than a year prior actually cleared the virus faster still, likely because natural infection in the interval had further boosted their immunity.

Modeling work confirmed the general principle: vaccinated individuals shed virus for a shorter period than unvaccinated people even when their initial viral trajectories look similar during the early, ramping-up phase of infection.¹⁵ For practical purposes, this means a vaccinated person who becomes infected after exposure is likely to be contagious for a somewhat shorter window. But the difference is measured in a day or two, not weeks, so it does not fundamentally change the quarantine math for most people.

Immunocompromised People Face a Different Timeline

The five-day-ish contagious window described above applies to people with reasonably healthy immune systems. For people who are significantly immunocompromised, the virus can persist in a replication-competent form for much longer. A systematic review found that people with blood cancers or solid organ transplants were especially likely to have prolonged shedding of both viral RNA and infectious virus.¹⁶ Case reports have documented immunocompromised patients shedding viable virus for weeks or even months, and importantly, this can occur even when the person feels well.¹⁷

People on dialysis face a similar issue. A study of hemodialysis patients infected with Omicron found that immunocompromised state, anemia, and low albumin levels were all associated with prolonged viral shedding.¹⁸ If you are quarantining because someone in your household is immunocompromised and has been exposed, or if you yourself are immunocompromised, standard timelines are likely not conservative enough. Test-based clearance strategies (waiting for two negative rapid tests 48 hours apart) are more appropriate than counting calendar days in these situations.

Household Exposure Is the Highest-Risk Setting

Not all exposures carry the same weight. A meta-analysis estimated the overall household secondary attack rate at about 17%, meaning roughly one in six household contacts of an infected person went on to develop COVID themselves.¹⁹ But that average hides dramatic variation. Attack rates were much higher from symptomatic index cases (about 18%) than from asymptomatic ones (under 1%). Spouses had the highest risk, at roughly 38%. In households with just one contact person, the rate reached over 40%. A separate contact-tracing study estimated even higher household attack rates, around 39%, with workplace and healthcare facility settings lower and air travel lower still.²⁰

The practical implication: a brief encounter with a colleague who later tests positive is a very different exposure than sleeping in the same room as a symptomatic partner. For the quick passing exposure, monitoring symptoms and testing once or twice may be reasonable. For the sustained household exposure, especially with a symptomatic index case, the probability that you caught the virus is high enough that behaving as if you are infected (masking around others, avoiding high-risk contacts) is prudent even before you test positive. Indoor ventilation and exposure duration are key variables too. One analysis of confirmed cases found that in a small, poorly ventilated room, the estimated critical exposure time with an infectious person was under one hour.²¹

Masking During Your Quarantine Window

If full quarantine is impractical, wearing a well-fitting mask around others provides meaningful reduction in transmission. A study in Johnson County, Iowa, found that when both the infected person and the contact wore masks, the secondary attack rate was cut roughly in half, from about 26% to about 13%. Longer exposure duration increased the rate, and the study’s authors noted that even with masking, attack rates were higher than expected, suggesting that quarantine remained beneficial on top of mask use.²² So masks help, but they are not a substitute for reducing close contact when you are in your highest-risk days after exposure.

Why People Struggle to Follow Quarantine Recommendations

Even during the height of the pandemic, actual compliance with quarantine was uneven. A systematic review found that adherence to self-isolation among confirmed cases ranged from about 51% to 86%, while contacts of cases reported somewhat higher compliance at 78% to 94%. People who only had COVID-like symptoms but no confirmed diagnosis had the lowest adherence, at around 16%.²³ Financial concerns were a major driver. An Israeli survey found that compliance was 94% when financial compensation was assumed but dropped below 57% when it was not.²⁴

This is worth keeping in mind because it shaped the evolution of public health guidance. Shorter quarantine recommendations were partly a scientific response to Omicron’s shorter incubation period, but they were also a pragmatic response to the reality that very few people were willing or able to isolate for ten to fourteen days. A cost-benefit analysis of quarantine policy in Iran found that from both an employee and government perspective, the economic benefits of quarantine outweighed the costs, with benefit-cost ratios well above one.²⁵ But those calculations depend on things like paid leave being available, which varies enormously from one country to the next.

How Different Countries Approached Quarantine Periods

Quarantine recommendations were never uniform globally. Early in the pandemic, the U.S. and U.K. told people with symptoms to isolate at home and end isolation only after being fever-free for at least 72 hours without medication, seeing improvement in other symptoms, and reaching at least seven days since symptom onset. Brazil and China went further, requiring all household members of a symptomatic person to quarantine for 14 days. South Korea took a different approach, asking symptomatic people to stay home for three to four days and then be contacted by public health officials for further direction.²⁶ Over time, most countries converged on shorter periods as evidence accumulated about Omicron’s faster incubation and as the practical impossibility of long quarantines became obvious.

Viral Rebound and What It Means for Ending Isolation

Some people experience what appears to be a recovery, then have a return of symptoms or a resurgence of detectable virus. This is called rebound, and it complicates the question of when you are truly in the clear. In a study of untreated COVID patients, about 12% had measurable viral rebound after initially declining, and 27% had symptom rebound after initial improvement. However, the combination of significant viral rebound alongside recurring symptoms was rare, occurring in only about 1-2% of participants.²⁷

Rebound received attention largely because of reports in people treated with the antiviral Paxlovid (nirmatrelvir/ritonavir). A large cohort study found that about 10-12% of hospitalized patients experienced virologic rebound regardless of whether they received antiviral treatment, suggesting the phenomenon is not unique to any particular drug.²⁸ The same study found that patients who did experience virologic rebound had a notably higher risk of health complications in the months that followed. The practical lesson: if your symptoms improve and then return, consider yourself potentially infectious again. Restart the clock and test before resuming close contact with others, especially vulnerable people.

Asymptomatic Infections Still Carry Risk

A common question during quarantine is: “I was exposed, I feel fine, am I really a risk to anyone?” The answer is yes, but a smaller one. A study of 39 asymptomatic carriers found that about 18% shed viable (culturable) virus, mostly within the first seven days after their initial positive PCR test.²⁹ And while the household secondary attack rate from asymptomatic index cases was under 1% in the meta-analysis mentioned earlier, that is not zero, particularly in prolonged household contact.¹⁹ A separate review found that even people who never developed symptoms had about a 17% chance of experiencing at least one long-term symptom afterward, including loss of taste or smell and fatigue, though this rate was about 80% lower than in people with symptomatic infections.³⁰

Children and School Settings

Children generally follow the same broad viral timeline as adults, but there are some wrinkles. A retrospective study of nearly 1,000 SARS-CoV-2 positive pediatric patients found that a subset had sustained positive tests over extended periods, and four cases of documented reinfection were observed.³¹ Prolonged PCR positivity in children sometimes caused headaches for schools that relied on test-based return policies, since a child could test PCR-positive for weeks after they were no longer contagious. This is the same PCR-versus-infectiousness gap seen in adults, but it created particular confusion for parents and school administrators. Rapid antigen tests, which better correlate with live-virus shedding, became the preferred tool for deciding when a child could safely return to the classroom.

The Origin of Quarantine Periods

The word “quarantine” itself traces back to fourteenth-century plague control. In 1377, the rector of the seaport of Ragusa (in what is now Croatia, then under the Venetian Republic) imposed a 30-day isolation period for arriving ships. Within a century, this had become a standard 40-day wait in ports across Italy and France, giving us the term quarantina, from the Italian for “forty days.”³² Similar approaches were later applied to tuberculosis and, in 2003, to SARS. The 40-day number had no particular scientific basis; it was a rough guess that happened to work for plague because the incubation period of bubonic plague is far shorter. Modern quarantine periods are calibrated to the specific pathogen’s incubation and infectious windows, which is why COVID quarantine recommendations shifted as new variants emerged with different kinetics.

1
The Lancet Microbe. Determinantes del periodo de incubación de SARS-CoV-2 y variantes de preocupación: un análisis de series de casos a partir de un estudio nacional de casos y contratos en Francia
2
PubMed Central. SARS-CoV-2 Incubation Period during the Omicron BA.5-Dominant Period in Japan
3
PubMed Central. Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2
4
PubMed Central. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
5
The Lancet Respiratory Medicine. Community transmission and dynamics of SARS-CoV-2 infectiousness and rapid antigen testing across the course of infection
6
PubMed Central. Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis
7
eLife. Evidence for transmission of COVID-19 prior to symptom onset
8
PubMed. Quantifying the presymptomatic transmission of COVID-19 in the USA
9
PubMed Central. Evaluation of the Diagnostic Accuracy of Nasal Cavity and Nasopharyngeal Swab Specimens for SARS-CoV-2 Detection via Rapid Antigen Test According to Specimen Collection Timing and Viral Load
10
PubMed Central. Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients
11
PubMed Central. Quantifying the impact of quarantine duration on COVID-19 transmission
12
PubMed Central. Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19
13
PubMed Central. Vaccination reduces viral load and accelerates viral clearance in SARS-CoV-2 Delta variant-infected patients
14
PubMed Central. Factors Influencing COVID-19 Viral Clearance: Implications for Vaccination and Antiviral Therapy
15
Scientific Reports. Individual-based modeling reveals that the COVID-19 isolation period can be shortened by community vaccination
16
PubMed Central. A Systematic Review of Prolonged SARS‐CoV‐2 Shedding in Immunocompromised Persons
17
PubMed Central. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts
18
PubMed. Immunocompromised states caused the prolonged duration of viral shedding in middle-aged and elderly hemodialysis patients infected with the Omicron variant of COVID-19
19
JAMA Network Open. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis
20
PubMed Central. Variability in transmission risk of SARS-CoV-2 in close contact settings: A contact tracing study in Shandong Province, China
21
PubMed Central. Estimate of the critical exposure time based on 70 confirmed COVID-19 cases
22
PubMed Central. Mask Effectiveness for Preventing Secondary Cases of COVID-19, Johnson County, Iowa, USA
23
PubMed. Measuring and increasing rates of self-isolation in the context of COVID-19: a systematic review with narrative synthesis
24
PubMed. Self-Isolation Compliance In The COVID-19 Era Influenced By Compensation: Findings From A Recent Survey In Israel
25
PubMed Central. Cost-benefit analysis of the quarantine policy during the outbreak of the Covid-19 virus in Iran
26
PubMed Central. Comparative analysis of COVID-19 guidelines from six countries: a qualitative study on the US, China, South Korea, the UK, Brazil, and Haiti
27
PubMed Central. Viral and Symptom Rebound in Untreated COVID-19 Infection
28
Nature Communications. SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study
29
PubMed Central. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
30
PubMed Central. Long-Term Consequences of Asymptomatic SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
31
Cureus. Sustained Positivity and Reinfection With SARS-CoV-2 in Children: Does Quarantine/Isolation Period Need Reconsideration in a Pediatric Population?
32
PubMed Central. The concept of quarantine in history: from plague to SARS